VLA 0.00% $1.75 viralytics limited

Looking forward to this .... Jun 05 Sunday 8:00 AM - 11:30 AM...

  1. 246 Posts.
    lightbulb Created with Sketch. 26
    Looking forward to this ....

    Jun 05
    Sunday
    8:00 AM - 11:30 AM
    Location: Hall A
    POSTER SESSION
    Developmental Therapeutics—Immunotherapy
    Track(s): Developmental Therapeutics and Translational Research

    Abstract TPS3108
    Phase I STORM study (KEYNOTE 200): Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21 in combination with pembrolizumab in advanced cancer patients.
    Poster Board: #423b
    Hardev S. Pandha, MD, PhD - Presenter
    University of Surrey

    https://iplanner.asco.org/am2016/#/session/11294
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.